Ygot, Estrella L.

HRN: 24-50-56  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/28/2025
09/03/2025
IVTT
500mg
Every 8hrs
Cholecystitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines